Journal profile · PHARMACOLOGY & PHARMACY
Prospects in Pharmaceutical Sciences
ISSN 2957-0468
Prospects in Pharmaceutical Sciences: CAS Zone 4 · Medicine (2026 Xinrui edition); impact factor 2.3 (journal website); diamond open access (no APC); no APC; 85 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
Prospects in Pharmaceutical Sciences is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Phytochemicals and Antioxidant Activities, Essential Oils and Antimicrobial Activity and Drug Solubulity and Delivery Systems, together about 30.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The journal offers Open Access publications of original and review articles in English in the field of pharmaceutical sciences: analysis, biochemistry, biopharmacy, biotechnology, clinical pharmacy, phytochemistry, herbal medicine, pharmaceutical care, drug synthesis, pharmaceutical technology, food and nutrition and related sciences, such as pharmacoeconomics, history of pharmacy or didactics in medical professions.
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY
Editor-in-chief Łukasz SzeleszczukPublisher website
Editorial board by country: none in mainland China; most named Poland 4, France 1, Pakistan 1 (6 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Phytochemicals and Antioxidant ActivitiesMedicine12.3%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences11%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics7.1%
- Natural product bioactivities and synthesisBiochemistry, Genetics and Molecular Biology5.3%
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences4.4%
- Diabetes Treatment and ManagementMedicine4%
- Fungal Biology and ApplicationsMedicine4%
- Bee Products Chemical AnalysisAgricultural and Biological Sciences4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceEmbasePublisher website
Other: Index Copernicus, GBL (Główna Biblioteka Lekarska), Google Scholar, Journal Citation Report 2025
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.3Publisher website ·
- 5-year impact factor (publisher)
- 2.3Publisher website ·
- h-index
- 13OpenAlex ·
- i10-index
- 18OpenAlex ·
- 2-year mean citedness
- 2.59OpenAlex ·
- Self-citation rate
- 8.7%LetPub ·
- Share of gold OA articles
- 89.4%LetPub ·
Volume
- Articles per year
- 58LetPub ·
Articles by year OpenAlex count · 288 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 10 | 10 | 1 |
| 2025 | 85 | 85 | 149 |
| 2024 | 65 | 65 | 265 |
| 2023 | 28 | 28 | 335 |
| 2022 | 8 | 8 | 3 |
| 2021 | 5 | 5 | 8 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| Publisher website | No APC | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–300 words
- Keywords
- ≥ 3
- Reference style
- Numbered, in order of citation
- Graphical abstract
- Optional
Article types accepted2
- original articlesThe journal offers Open Access publications of original and review articles in English in the field of pharmaceutical sciencesLength not stated
- review articlesThe journal offers Open Access publications of original and review articles in English in the field of pharmaceutical sciencesLength not stated
Policy excerpts from the journal's websiteAI use, License & copyright, Open access
- AI use 12. Use of Artificial Intelligence (AI) Tools
Authors may use artificial intelligence (AI) tools solely to improve the language, grammar, readability, or formatting of their manuscripts. AI tools may also assist with code development or data visualization, provided that all outputs are carefully verified by the authors. AI tools must not be listed as authors, as they cannot assume responsibility for the scientific content of the manuscript. A…
Source ↗Publisher website ·- License & copyright Copyright Notice
For all articles published in Prospects in Pharmaceutical Sciences copyright is retained by the authors. The journal publishes articles in the Open Access policy, within the CC BY 4.0 licence.
Source ↗Publisher website ·- Open access
Immediate Open Access permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, free of any charge. Model summary
Prospects in Pharmaceutical Sciences offers immediate Open Access to its publications, permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, free of any charge.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- ISSN
- 2957-0468
- Society / sponsor
- Faculty of Pharmacy of the Medical University of Warsaw
- Official links
FAQ
Frequently asked questions about Prospects in Pharmaceutical Sciences
What CAS zone is Prospects in Pharmaceutical Sciences in?
In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Prospects in Pharmaceutical Sciences?
The journal's website gives an impact factor of 2.3; this is the journal's own figure, as LetPub lists none for it; h-index 13.
What are the manuscript requirements of Prospects in Pharmaceutical Sciences?
According to the journal's author guidelines: Abstract: 150–300 words; Keywords: ≥ 3; Reference style: Numbered, in order of citation; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Prospects in Pharmaceutical Sciences based?
Of the 6 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Poland (4), France (1) and Pakistan (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Prospects in Pharmaceutical Sciences?
According to LetPub and DOAJ records, Prospects in Pharmaceutical Sciences is indexed in ESCI and DOAJ. The journal's website also lists Web of Science and Embase; that list has not been checked against each database.
Is Prospects in Pharmaceutical Sciences open access, and what is the APC?
Prospects in Pharmaceutical Sciences is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-30). Last updated: .